Hasegawa T - Search Results

1

Prodrugs of 2',3'-dideoxyinosine (DDI): improved oral bioavailability via hydrophobic esters.

Kawaguchi T, Hasegawa T, Seki T, Juni K, Morimoto Y, Miyakawa A, Saneyoshi M. Kawaguchi T, et al. Among authors: hasegawa t. Chem Pharm Bull (Tokyo). 1992 May;40(5):1338-40. doi: 10.1248/cpb.40.1338. Chem Pharm Bull (Tokyo). 1992. PMID: 1394659 Free article.

2

Prodrugs of 2',3'-didehydro-3'-deoxythymidine.

Hasegawa T, Seki T, Juni K, Saneyoshi M, Kawaguchi T. Hasegawa T, et al. J Pharm Sci. 1993 Dec;82(12):1232-6. doi: 10.1002/jps.2600821210. J Pharm Sci. 1993. PMID: 8308702

3

Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres.

Kawaguchi T, Tsugane A, Higashide K, Endoh H, Hasegawa T, Kanno H, Seki T, Juni K, Fukushima S, Nakano M. Kawaguchi T, et al. Among authors: hasegawa t. J Pharm Sci. 1992 Jun;81(6):508-12. doi: 10.1002/jps.2600810606. J Pharm Sci. 1992. PMID: 1387895

4

Controlled release of 5-fluoro-2'-deoxyuridine by the combination of prodrug and polymer matrix.

Endoh H, Kawaguchi T, Seki T, Hasegawa T, Juni K. Endoh H, et al. Among authors: hasegawa t. Chem Pharm Bull (Tokyo). 1991 Feb;39(2):458-64. doi: 10.1248/cpb.39.458. Chem Pharm Bull (Tokyo). 1991. PMID: 1829027

5

Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats.

Seki T, Sato N, Hasegawa T, Kawaguchi T, Juni K. Seki T, et al. Among authors: hasegawa t. Biol Pharm Bull. 1994 Aug;17(8):1135-7. doi: 10.1248/bpb.17.1135. Biol Pharm Bull. 1994. PMID: 7820125 Free article.

6

Future of prodrugs in antiviral therapy.

Hasegawa T, Kawaguchi T. Hasegawa T, et al. Clin Pharmacokinet. 1994 Nov;27(5):331-6. doi: 10.2165/00003088-199427050-00001. Clin Pharmacokinet. 1994. PMID: 7851051 Review. No abstract available.

7

Synthesis and investigation of N4-substituted cytarabine derivatives as prodrugs.

Fadl TA, Hasegawa T, Youssef AF, Farag HH, Omar FA, Kawaguchi T. Fadl TA, et al. Among authors: hasegawa t. Pharmazie. 1995 Jun;50(6):382-7. Pharmazie. 1995. PMID: 7651974

8

Novel stabilizing method for antisense oligodeoxynucleotides.

Sueishi T, Seki T, Juni K, Hasegawa T, Saneyoshi M, Kawaguchi T. Sueishi T, et al. Among authors: hasegawa t. Pharm Res. 1994 Mar;11(3):455-7. doi: 10.1023/a:1018933608926. Pharm Res. 1994. PMID: 8008716 No abstract available.

9

Potential usefulness of solubility index for prediction of the skin permeation rate of 5-ISMN from pressure-sensitive adhesive tape.

Sato K, Mitsui N, Hasegawa T, Sugibayashi K, Morimoto Y. Sato K, et al. Among authors: hasegawa t. J Control Release. 2001 Jun 15;73(2-3):269-77. doi: 10.1016/s0168-3659(01)00301-7. J Control Release. 2001. PMID: 11516504

10

Effects of application voltage and cathode and anode positions at electroporation on the in vitro permeation of benzoic acid through hairless rat skin.

Yoshida M, Mori K, Watanabe T, Hasegawa T, Sugibayash K. Yoshida M, et al. Among authors: hasegawa t. Chem Pharm Bull (Tokyo). 2000 Nov;48(11):1807-9. doi: 10.1248/cpb.48.1807. Chem Pharm Bull (Tokyo). 2000. PMID: 11086923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,494 results

Search Page

Filters